Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Kralev, Stefan ^a   Schneider, Kathrin ^a   Lang, Siegfried ^a   Süselbeck, Tim ^a   Borggrefe, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGITALIS GLYCOSIDE; FLECAINIDE; PHENPROCOUMON; PROPAFENONE;

AGE; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; FRAMINGHAM RISK SCORE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PROSPECTIVE STUDY; SMOKING; ANGIOPLASTY; CLINICAL TRIAL; PATHOLOGY; RADIOGRAPHY;

ANGINA;

AGED; ANGIOPLASTY; ATRIAL FIBRILLATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE;

EID: 80052999262     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024964     Document Type: Article

References (34)

1. Go AS, Hylek EM, Philips KA, Chang Y, Henault LE, Selby JV, et al. (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) Study. JAMA 285: 2370-5.
2. Paquette M, Roy D, Talajic M, Newman D, Couturier A, et al. (2000) Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol 86 (7): 764-8.
3. Kannel WB, Abbott RD, Savage DD, McNamara PM, (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306 (17): 1018-22.
4. Pizzenetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, et al. (2001) GISSI-3 Investigators. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart 86 (5): 527-532.
5. Gersh BJ, Tsang TSM, Barnes ME, Seward JB, (2005) The changing epidemiology of non-valvular atrial fibrillation: The role of novel risk factors. Eur Heart J Supplements 7 (Suppl C): C5-C11.
6. Wilhelmsen L, Rosengren A, Lappas G, (2001) Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med 250 (5): 382-389.
7. Kannel WB, Abbott RD, Savage DD, McNamara PM, (1983) Coronary heart disease and atrial fibrillation: The Framingham study. Am Heart J 106 (2): 389-396.
8. Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, et al. (1991) Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol 68: 335-41.
9. AFFIRM Investigators (2002) Baseline characteristics of patients with atrial fibrillation: the AFFIRM study. Am Heart J 143 (6): 991-1001.
10. Lip GYH, Beevers DG, (1995) History, epidemiology and importance of atrial fibrillation. BMJ 311 (7016): 1361-3.
11. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE, (1995) The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Manitoba Follow-Up Study. Am J Med 98: 476-84.
12. Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, et al. (2009) ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 360: 668-678.
13. Otterstad JE, Kirwan BA, Lubsen J, De Brouwer S, Fox KA, et al. (2006) Action Investigators. Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease. Scandinavian cardiovascular journal 40: 152-159.
14. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS, (1988) Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol 61: 714-717.
15. Haddad AH, Prchkov VK, Dean DC, (1978) Chronic atrial fibrillation and coronary artery disease. J Electrocardiol 11: 67-9.
16. Cheng TO, (1974) Coronary artery disease as an uncommon cause of chronic atrial fibrillation. Clin Res 22: 268A.
17. Zipes DP, (1984) Specific Arrhythmias: Diagnosis and Treatment. In: Braunwald E, editors. Heart Disease. A Textbook of Cardiovascular Medicine Philadelphia W.B. Saunders.
18. Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JGP, et al. (2010) Race II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 362 (15): 1439-1441.
19. Choi EK, Choi SI, Rivera JJ, Nasir K, Chang SA, et al. (2008) Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. J Am Coll Cardiol 52 (5): 357-65.
20. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Eur Heart J 31 (19): 2369-429.
21. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, et al. (2008) Williams DO. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for the Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 117: 261-295.
22. Movahed MR, Hashemzadeh M, Jamal MM, (2005) Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 105 (3): 315-8.
23. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, et al. (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (22): 2864-70.
24. Van Walraven WC, Hart RG, Wells GA, Petersen P, Koudstaal PJ, et al. (2003) A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 163 (8): 936-43.
25. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ, (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on Atrial Fibrillation. Chest 137: 263-272.
26. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, et al. (1994) Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74 (3): 236-41.
27. Watson S, Arya A, Sulke N, Lip GY, (2010) Relationship of indices of Inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation. Chest 137 (4): 869-876.
28. Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H, (1992) Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur Heart J 13 (1): 45-50.
29. Goldberg RJ, Seeley D, Becker RC, Brady P, Chen ZY, et al. (1990) Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. Am Heart J 119 (5): 996-1001.
30. Min SY, Park DW, Yun SC, Kim YH, Lee JY, et al. (2010) Major predictors of long-term clinical outcomes after coronary revascularization in patients with unprotected left main coronary disease: analysis from the MAIN-COMPARE study. Circ Cardiovasc Interv 3 (2): 127-133.
31. Lokshyn S, Mewis C, Kuhlkamp V, (2000) Atrial fibrillation in coronary artery disease. Int J Cardiol 72 (2): 133-6.
32. Dewar RI, Lip GYH, (2007) Identification, diagnosis and assessment of atrial fibrillation. Heart 93: 25-28.
33. Lévy S, Mareek M, Coumel P, Guize L, Lekieffre J, et al. (1999) Characterization of different subsets of atrial fibrillation in general practice in France. The ALFA study. The college of French Cardiologists. Circulation 99 (23): 3028-35.
34. Ruiz-Nodar JM, Marin F, Manzano-Fernandez S, Valencia-Martin J, Hurtado JA, et al. (2010) An evaluation of the CHADS2 stroke risk score in patients with atrial fibrillation undergoing percutaneous coronary revascularisation. Chest Sep 23. [Epub ahead of print].